ACB Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

4.465

Open

4.400

VWAP

4.00

Vol

605.00K

Mkt Cap

248.00M

Low

4.320

Amount

3.00M

EV/EBITDA(TTM)

--

Total Shares

57.00M

EV

374.00M

EV/OCF(TTM)

110.00

P/S(TTM)

1.00

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The Company also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Show More

Events Timeline

(ET)

2025-12-26

13:40:00

Trump Reaches Agreements with Pharma Companies to Lower Drug Prices

2025-12-24 (ET)

2025-12-24

09:50:00

Trump Delays New Tariffs on Chinese Chips for 18 Months

2025-12-23 (ET)

2025-12-23

15:10:00

Trump Instructs Attorney General to Expedite Marijuana Rescheduling

2025-12-19 (ET)

2025-12-19

10:10:00

Trump Signs Executive Order on Marijuana Research to Improve CBD Access

2025-12-18 (ET)

2025-12-18

16:30:00

Major Averages Rise as CPI Data Surprises Investors

2025-12-18

15:40:00

Trump Signs Executive Order to Reclassify Cannabis as Schedule III Drug

2025-12-18

14:20:00

Trump Signs Executive Order to Enhance Medical Marijuana Research

2025-12-18

07:10:00

Aurora Cannabis Launches New Brand Daily Special for German Market

News

an image of Benzinga

Roundhill Cannabis ETF (BATS: WEED) Momentum Soars to 89.25 Amid Federal Reform Optimism

an image of PRnewswire

01-20PRnewswire

Aurora Cannabis Secures EU Plant Variety Rights, Strengthening Genetic Leadership

an image of Benzinga

Trump's Executive Order Urges Cannabis Rescheduling, Potentially Eliminating 280E Tax Burden

an image of PRnewswire

01-14PRnewswire

Aurora Cannabis Advances Powdery Mildew-Resistant Cultivar Research, Commercialization Imminent

an image of Newsfilter

01-14Newsfilter

Aurora Cannabis Advances Powdery Mildew-Resistant Cultivar Research, Commercialization Imminent

an image of Fool

Trump Reschedules Cannabis to Schedule 3, Potentially Boosting Canopy and Aurora

1 Analyst Rating

Wall Street analysts forecast ACB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACB is 4.32 USD with a low forecast of 4.32 USD and a high forecast of 4.32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

1 Hold

0 Sell

Hold

Current: 0.000

Low

4.32

Averages

4.32

High

4.32

Current: 0.000

Low

4.32

Averages

4.32

High

4.32

an image of No data

No data

Valuation Metrics

The current forward P/E ratio for Aurora Cannabis Inc (ACB.O) is -19.87, compared to its 5-year average forward P/E of -56.74. For a more detailed relative valuation and DCF analysis to assess Aurora Cannabis Inc 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

an image of dotted line Image

N/A

5Y Average PE

-56.74

Current PE

-19.87

Overvalued PE

298.10

Undervalued PE

-411.58

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

an image of dotted line Image

N/A

5Y Average EV/EBITDA

-10.21

Current EV/EBITDA

8.60

Overvalued EV/EBITDA

39.22

Undervalued EV/EBITDA

-59.63

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

an image of dotted line Image

5Y Average PS

2.85

Current PS

0.88

Overvalued PS

5.56

Undervalued PS

0.14

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

marijuana stocks

Intellectia · 8 candidates

Market Cap: >= 200.00MRegion: US, CanadaPrice: >= $1.00Themes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 300,000

Ticker

Name

Market Cap$

Scotts Miracle-Gro Co

4.00B

Innovative Industrial Properties Inc

1.00B

Tilray Brands Inc

1.00B

Cronos Group Inc

999.00M

Canopy Growth Corp

461.00M

SNDL Inc

407.00M

Top cannabis stocks to buy

Intellectia · 9 candidates

Market Cap: >= 50.00MRevenue Ttm: >= 10.00MThemes: The Cannabis Industry

Ticker

Name

Market Cap$

Scotts Miracle-Gro Co

4.00B

Innovative Industrial Properties Inc

1.00B

Tilray Brands Inc

1.00B

Cronos Group Inc

999.00M

Canopy Growth Corp

461.00M

SNDL Inc

407.00M

Whales Holding ACB

Trading Trends

People Also Watch

Frequently Asked Questions

What is Aurora Cannabis Inc (ACB) stock price today?

The current price of ACB is 4.42 USD — it has increased 2.31 % in the last trading day.

What is Aurora Cannabis Inc (ACB)'s business?

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The Company also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

What is the price predicton of ACB Stock?

Wall Street analysts forecast ACB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACB is4.32 USD with a low forecast of 4.32 USD and a high forecast of 4.32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Aurora Cannabis Inc (ACB)'s revenue for the last quarter?

Aurora Cannabis Inc revenue for the last quarter amounts to 90.00M USD, increased 11.40 % YoY.

What is Aurora Cannabis Inc (ACB)'s earnings per share (EPS) for the last quarter?

Aurora Cannabis Inc. EPS for the last quarter amounts to -0.91 USD, increased 313.64 % YoY.

How many employees does Aurora Cannabis Inc (ACB). have?

Aurora Cannabis Inc (ACB) has 1101 emplpoyees as of January 28 2026.

What is Aurora Cannabis Inc (ACB) market cap?

Today ACB has the market capitalization of 248.00M USD.